Madrigal Pharmaceuticals Inc (LTS:0JXI)
$ 544.11 -0.62 (-0.11%) Market Cap: 12.56 Bil Enterprise Value: 12.09 Bil PE Ratio: 0 PB Ratio: 23.10 GF Score: 28/100

Madrigal Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript

Jun 10, 2026 / 03:20PM GMT
Release Date Price: $478.37 (+0.71%)
Unidentified Participant

Great. Well, first I'd like to welcome Mardigal Pharmaceuticals, CEO, Bill Sibold; CFO, Mardi Dier; and CMO, Dave Soergel. Welcome to the Goldman Healthcare Conference.

Questions & Answers

Unidentified Participant

Maybe first starting on the launch. Can you give us an update of how it's progressing, some highlights from the last 12 months, and what investors should be looking for the rest of the year?

Bill Sibold
Madrigal Pharmaceuticals Inc - President, Chief Executive Officer, Director

Well, first of all, thanks for having us. It's always great to be at the conference and it's always good when you have a conference like this to look back what's happened since the last time we were here. So when you look back over the last 12 months, it's been really quite a remarkable 12 months for us, transformational in any ways. We've continued to have a best in industry launch with Rezdiffra over the last 12 months.

We've seen that we are part of a market that is growing rapidly and we're at the very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot